INBIO VENTURES
We are the ambitious team of professionals with comprehensive experience in academic and biopharmaceutical industry, drug discovery and development, venture investments. We are supported by the Advisory Board of internationally recognized KOLs in various therapeutic areas. We are dedicated to investing in breakthrough drug development projects worldwide.
INBIO VENTURES
Social Links:
Founded:
2013-01-01
Status:
Active
Contact:
+74959884795
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Yoast Plugins
Similar Organizations
lool Ventures
lool Ventures is a venture capital firm that invests in early stage Israeli startups.
Twig Ventures
Twig Ventures is a venture capital firm with a focus on early-stage start-ups.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-12-05 | Neon Therapeutics | Inbio Ventures investment in Series B - Neon Therapeutics | 36 M USD |
| 2017-01-05 | Neon Therapeutics | Inbio Ventures investment in Series B - Neon Therapeutics | 70 M USD |
| 2016-08-18 | Avelas Biosciences | Inbio Ventures investment in Series C - Avelas Biosciences | 20 M USD |
| 2016-07-12 | TransMedics | Inbio Ventures investment in Private Equity Round - TransMedics | 12.5 M USD |
| 2016-05-26 | TransMedics | Inbio Ventures investment in Series F - TransMedics | 51.2 M USD |
| 2016-03-15 | Argos Therapeutics | Inbio Ventures investment in Post-IPO Equity - Argos Therapeutics | 60 M USD |
| 2015-12-09 | Allena Pharmaceuticals | Inbio Ventures investment in Series C - Allena Pharmaceuticals | 53 M USD |
| 2015-07-16 | Protagonist Therapeutics | Inbio Ventures investment in Series C - Protagonist Therapeutics | 40 M USD |
| 2015-04-23 | Jounce Therapeutics | Inbio Ventures investment in Series B - Jounce Therapeutics | 56 M USD |
| 2015-01-26 | enGene | Inbio Ventures investment in Series B - enGene | 11.5 M USD |